The global Drug Repurposing Market, valued at US$ 28.9 billion in 2023, is poised for robust expansion according to recent industry analysis. The market is projected to grow at a CAGR of 4.7% from 2024 to 2034, ultimately reaching an impressive US$ 47.8 billion by the end of 2034. The surge is driven by faster development timelines, reduced clinical failure rates, advances in computational biology, and the rising demand for affordable therapies across multiple disease categories.
Market Overview
Drug repurposing—also known as drug repositioning or drug rediscovery—has emerged as an essential approach within modern pharmaceutical innovation. Instead of creating new compounds from scratch, researchers identify new therapeutic uses for existing molecules, accelerating drug development and substantially lowering cost and risk. As healthcare systems globally face mounting pressure to improve treatment accessibility while curbing expenses, drug repurposing has moved from an alternative strategy to a mainstream scientific and commercial imperative.
Market Size and Growth
From US$ 28.9 billion in 2023, the market is forecast to steadily expand to US$ 47.8 billion by 2034, driven by increased investment from pharmaceutical companies, breakthrough discoveries in oncology and neurology, and the integration of artificial intelligence in drug discovery pipelines. The 4.7% CAGR reflects a sustainable growth trajectory influenced by regulatory support, improved biomarker identification, and rising public–private research collaborations.
Market Segmentation
The market spans several key segments, including:
- By Drug Type: small molecules, biologics, and orphan drugs.
- By Therapeutic Area: oncology, infectious diseases, neurological disorders, rare diseases, cardiovascular diseases, and others.
- By End User: pharmaceutical companies, biotechnology firms, academic research institutes, and CROs.
This diversification allows multiple stakeholders—from startups to major pharmaceutical firms—to participate in the innovation process.
Regional Analysis
North America remains the largest regional market due to its advanced healthcare infrastructure, strong regulatory support for repurposed drugs, and concentration of leading pharmaceutical companies. Europe follows closely, driven by rising investments in rare disease research and cross-border scientific collaborations. Meanwhile, the Asia Pacific region is experiencing accelerating growth owing to cost-effective clinical research capabilities, expanding biotechnology ecosystems, and increasing healthcare expenditures in China and India.
Market Drivers and Challenges
Key market growth drivers include reduced development timelines, cost-effectiveness, growing unmet medical needs, and advancements in AI-based modeling. However, challenges persist in areas such as intellectual property protection, regulatory complexities, and competition among generics once a repurposed drug loses exclusivity.
Market Trends
Prominent trends include the adoption of machine learning for target identification, increasing partnerships between biotech startups and major pharmaceutical companies, an expanding focus on rare diseases, and the rising importance of real-world evidence in evaluating new indications for existing drugs.
Competitive Landscape
Industry leaders such as Algernon Pharmaceuticals, Biovista Inc., Celentyx Ltd., ChemBio Discovery Inc., Chord Therapeutics SA, Excelra, Fios Genomics Ltd., Lantern Pharma Inc., Novartis AG, Paradigm Biopharmaceuticals Limited, Predictive Oncology, Segue Therapeutics LLC, and Teva Pharmaceutical Industries Ltd. are advancing the field with cutting-edge repositioning programs, AI-powered discovery platforms, and strategic partnerships.
About Transparency Market Research
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools techniques to gather and analyses information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact:
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
